UK. Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic : MHRA
Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic
The MHRA, jointly with the with the Department of Health and the Home Office, have issued proposals for changes to legislation and working procedures during an influenza pandemic (consultation letter MLX 355 and accompanying Impact Assessment).
MLX 355 is in six parts:
Part 1: Proposals to amend legislation governing the emergency supply of prescription only medicines, not restricted only to the circumstances of an influenza pandemic
Part II: Proposals for changes to legislation governing the manufacture, distribution, sale and supply of medicines during an influenza pandemic
Part III: Proposals for changes to legislation governing whole blood and blood components during an influenza pandemic
Part IV: Proposals concerning the availability of medical devices during an influenza pandemic
Part V: Proposals for changes to the legislation governing the supply of controlled drugs during an influenza pandemic
Part VI: Proposals for changes to NHS Pharmaceutical Services Regulations in England, Wales and Northern Ireland and related aspects of the relevant drug tariffs during an influenza pandemic
[Scotland will be consulting separately on any necessary changes to the NHS (Pharmaceutical Services) (Scotland) Regulations 1995 and any related aspects of the Scottish Drug Tariff.]
This consultation is open for 6 weeks.
Responses should arrive no later than 20 March 2009.
Responses should be sent to Mr Roy Drepaul at the address below: MHRA16-139 - Market Towers 1 - Nine Elms Lane - LondonSW8 5NQ
or e-mail to Part3@mhra.gsi.gov.uk
-
Download documents:
* 1. Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic (374Kb)
* 2. Public consultation (MLX 355): Annexes (339Kb)
* 3. Public consultation (MLX 355): Impact Assessment (389Kb)
* 4. Public consultation (MLX 355): Consultation list (102Kb)
-
<cite cite="http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON038669">Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic : MHRA</cite>
The MHRA, jointly with the with the Department of Health and the Home Office, have issued proposals for changes to legislation and working procedures during an influenza pandemic (consultation letter MLX 355 and accompanying Impact Assessment).
MLX 355 is in six parts:
Part 1: Proposals to amend legislation governing the emergency supply of prescription only medicines, not restricted only to the circumstances of an influenza pandemic
Part II: Proposals for changes to legislation governing the manufacture, distribution, sale and supply of medicines during an influenza pandemic
Part III: Proposals for changes to legislation governing whole blood and blood components during an influenza pandemic
Part IV: Proposals concerning the availability of medical devices during an influenza pandemic
Part V: Proposals for changes to the legislation governing the supply of controlled drugs during an influenza pandemic
Part VI: Proposals for changes to NHS Pharmaceutical Services Regulations in England, Wales and Northern Ireland and related aspects of the relevant drug tariffs during an influenza pandemic
[Scotland will be consulting separately on any necessary changes to the NHS (Pharmaceutical Services) (Scotland) Regulations 1995 and any related aspects of the Scottish Drug Tariff.]
This consultation is open for 6 weeks.
Responses should arrive no later than 20 March 2009.
Responses should be sent to Mr Roy Drepaul at the address below: MHRA16-139 - Market Towers 1 - Nine Elms Lane - LondonSW8 5NQ
or e-mail to Part3@mhra.gsi.gov.uk
-
Download documents:
* 1. Public consultation (MLX 355): Proposals for changes to legislation and working procedures during an influenza pandemic (374Kb)
* 2. Public consultation (MLX 355): Annexes (339Kb)
* 3. Public consultation (MLX 355): Impact Assessment (389Kb)
* 4. Public consultation (MLX 355): Consultation list (102Kb)
-